Insider · CIK 0001942990
Lawrence Corey
Files at GRTS (Gritstone bio, Inc.). First filing -, latest -.
In brief
Lawrence Corey files SEC Form 4 as director at GRTS (Gritstone bio, Inc.). No open-market trade is on file; the transactions below are grants, exercises and other rows that carry no view on the price.
A track record needs three past buys with six months of prices behind them; Lawrence Corey has 0, so none is measured yet.
Signals
This insider’s open-market buys and sells, scored.
Transactions
Every row this insider has filed, 3 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Apr 4, 2025 | GRTS Gritstone bio, Inc. | JOther Stock Option (Right to Buy)derivative | -51,800 | $0.00 | $0 | 0 | Apr 8, 2025 |
| Apr 4, 2025 | GRTS Gritstone bio, Inc. | JOther Stock Option (Right to Buy)derivative | -51,800 | $0.00 | $0 | 0 | Apr 8, 2025 |
| Apr 4, 2025 | GRTS Gritstone bio, Inc. | JOther Stcok Option (right to buy)derivative | -38,000 | $0.00 | $0 | 0 | Apr 8, 2025 |
Questions about Lawrence Corey
Answered from the filings on this page, as of the latest one.
Is Lawrence Corey buying or selling?
Lawrence Corey has no open-market buy or sell on SEC Form 4; the filings on record are grants, exercises and other transactions.
How did Lawrence Corey's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Lawrence Corey has 0.
Where does Lawrence Corey file Form 4?
Lawrence Corey has filed Form 4 at GRTS (Gritstone bio, Inc.). A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.